Website profile

Biospace

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES V

  • 281articles · 30d
  • 5+ hour agolatest article
  • Aug 17, 2026earliest in window
  • 91%with images
  • 289avg words
articles per day
Categories
  • Economy, Business & Finance 160
  • Health & Wellness 129
  • Medical 128
  • Business & Industrial 117
  • Finance & Business 105
  • Health 59
  • Science & Technology 48
  • Science & Nature 33

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

BioSpace
biospace.com > business > novartis-board-faces-investor-scrutiny-after-m-a-misfires-and-r-d-flops

Novartis’ board faces investor scrutiny after M&A misfires and R&D flops

3+ day, 4+ hour ago   (469+ words) Novartis went into September looking forward to three readouts that analysts had identified as central to its mid- to long-term growth prospects. Days later, the Swiss drugmaker was reeling from the failures of two of the pivotal trials, offsetting success in…...

BioSpace
biospace.com > press-releases > prime-therapeutics-names-manmohan-mahajan-chief-financial-officer

Prime Therapeutics names Manmohan Mahajan chief financial officer

3+ day, 9+ hour ago   (255+ words) EAGAN, Minn., Sept. 10, 2026 /PRNewswire/ -- Prime Therapeutics LLC (Prime) today announced that Manmohan Mahajan has been appointed as the company's chief financial officer (CFO), effective immediately. Mahajan brings more than 20 years of global finance and leadership experience across healthcare, pharmacy and…...

BioSpace
biospace.com > business > takedas-long-term-r-d-head-announces-exit-after-major-pipeline-reorganization

Takeda’s long-term R&D head announces exit after major pipeline reorganization

3+ day, 17+ hour ago   (499+ words) iStock, Agdekon Media Visuals Takeda’s R&D chief Andy Plump will say good-bye to the drugmaker, with a retirement slated for next summer. “Andy has made the personal decision to retire in June 2027 after more than 10 years leading Takeda’s global…...

BioSpace
biospace.com > press-releases > innate-pharma-to-host-conference-call-and-webcast-on-september-17-for-first-half-2026-financial-results-and-business-update

Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update

4+ day, 36+ min ago   (133+ words) Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, September 17, 2026 at 2:00 p.m. CEST / 8:00 a.m. EDT, to provide a business update for the first…...

BioSpace
biospace.com > press-releases > turn-therapeutics-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum

Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum

3+ day, 20+ hour ago   (194+ words) BioSpace Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, localized therapies for inflammatory skin diseases, today announced that Bradley Burnam, Chief…...

Google News
biospace.com > press-releases > lsl-pharma-group-announces-cfo-transition

LSL PHARMA GROUP ANNOUNCES CFO TRANSITION

4+ day, 2+ hour ago   (173+ words) BOUCHERVILLE, QC, Sept. 10, 2026 /CNW/ -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, today announced that Luc Mainville will be leaving his position as Chief Financial Officer of the Corporation, effective immediately. LSL…...

BioSpace
biospace.com > press-releases > iqvia-announces-pricing-of-senior-notes-september-9-2026

IQVIA Announces Pricing of Senior Notes - September 9, 2026

4+ day, 6+ hour ago   (574+ words) BioSpace IQVIA Announces Pricing of Senior Notes - September 9, 2026 RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $2,000,000,000 in aggregate principal amount of senior…...

BioSpace
biospace.com > press-releases > electromed-inc-to-participate-in-the-h-c-wainwright-28th-annual-global-investment-conference-and-ld-micro-20th-annual-main-event

Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event

4+ day, 7+ hour ago   (195+ words) BioSpace Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced their attendance…...

BioSpace
biospace.com > press-releases > latus-bio-appoints-donald-hayden-as-chairman-of-the-board-and-michael-maclean-as-independent-director-and-audit-committee-chair

Latus Bio Appoints Donald Hayden as Chairman of the Board and Michael MacLean as Independent Director and Audit Committee Chair

4+ day, 22+ hour ago   (626+ words) BioSpace Latus Bio Appoints Donald Hayden as Chairman of the Board and Michael MacLean as Independent Director and Audit Committee Chair Bristol Myers Squibb and seasoned biotechnology veteran Donald Hayden, M.B.A., appointed as Chairman of the Latus Board of Directors Former…...

BioSpace
biospace.com > press-releases > great-point-partners-iii-sells-mlm-medical-labs-to-labcorp

Great Point Partners III Sells MLM Medical Labs to Labcorp

4+ day, 20+ hour ago   (464+ words) BioSpace Great Point Partners III Sells MLM Medical Labs to Labcorp GREENWICH, Conn. and MÖNCHENGLADBACH, Germany--(BUSINESS WIRE)--Great Point Partners (“GPP”), a Greenwich-based private investment firm focused exclusively on the health care industry, is pleased to announce that it…...